MAOB and central nervous system cancer: Therefore, we evaluated for the first time the biological effects of two novel MAO-B inhibitors, which were synthesized in our medicinal chemistry laboratory, on the C6 glioma cell line and on CTX TNA2 non-tumoral astrocytes, in terms of cell proliferation, apoptosis occurrence, inflammatory events and cell migration in order to improve the design and the assessment of anti-glioma therapies.